Animal Microbiome Market | Size, Share and Scope Analysis to 2031

The newly published report titled "Global Animal Microbiome Market- By Trends, Industry Competition Analysis, Revenue (US$ Millions) and Forecast Till 2030." of InsightAce Analytic Pvt. Ltd. features in-depth analysis and an extensive study on the market, exploring its significant factors.

According to the latest market intelligence research report by InsightAce Analytic, the global Animal Microbiome market size was valued at US$ 5.75 Billion in 2021, and it is expected to reach US$ 12.4 Billion in 2030, recording a promising CAGR of 9.0% during the forecast period of 2022 to 2030.

Request Demo Sample Report: https://www.insightaceanalytic.com/request-sample/1046

Sustainability in livestock production has received considerable attention in recent years. The microbiome has become a valuable target for products that seek to improve the sustainability of animal production, thereby driving both sustainability and productivity. Animal microbiome research focuses on the microbial populations that inhabit animals to determine their role in health, disease, and development. The microbiome of an animal is essential for gastrointestinal health, immune function, and digestion. 70% of immune cells are found in the gastrointestinal tract of poultry, highlighting the significance of the gut to overall health. The gastrointestinal microbiome influences productivity and microbiological safety in addition to animal health.

The market expansion can be attributed to the rising demand for identifying, treating, and preventing diseases in livestock and companion animals, as well as the expanding pet population. In the past year, increased companion ownership and rising livestock populations have led to a rapid expansion of the market. In recent years, dietary supplements that promote immune health have acquired popularity. The demand for the animal microbiome is anticipated to increase as a result of increased pet expenditures, which will increase the demand for safe and nutrient-rich products to keep canines healthy. Increased emphasis on animal health innovation has manifested in a number of factors bolstering the growth prospects of the industry. Animal microbiome technological advancements, such as the advent of microbiome DNA sequencing and cutting-edge bioinformatics analysis, also contribute to market growth. Increased demand for meat and meat products, increased concern regarding antibiotic resistance to enhance gut health, and the rising importance of protein-rich diets are likely to contribute to the market's expansion over the forecast period.

Preview for Detailed TOC: https://www.insightaceanalytic.com/report/global-animal-microbiome-market/1046

According to Association for Pet Obesity Prevention, 56% of dogs and 60% of cats were overweight or obese in 2018. Extra weight in pets may show to conditions such as high blood pressure, difficulty breathing, arthritis, joint health matters, as well as a weakened immune system. Key companies focus on product development such as early detection and predictive microbiome-based modes to provide more effective methods for managing chronic diseases in animals. For instance, In May 2021, Gnubiotics Sciences SA announced the allowance patent of microbiome markers for identifying, predicting, and treating pet obesity from the European Patent Office. This is considered as the first covering a microbiome-based theory to predict, diagnose and treat feline obesity, a significant cause of diabetes and chronic kidney disease (CKD) in felines.

The prominent players in the Animal Microbiome industry include:
Adisseo France SAS, Animal Biome, Inc, ANIZOME LLC, Arm & Hammer Animal Nutrition, Cargill, Chr. Hansen Holding A/S, Cytophage Technologies Inc., DuPont Industrial Biosciences, Elanco Animal Health, Eligo Bioscience, EnBiotix, Inc., FermBiotics, FOLIUM Science, Gnubiotics Sciences SA, Hill's Pet Nutrition, Inc., Intralytix, ISOThrive , Jefo Nutrition Inc., Koninklijke DSM N.V. (Royal DSM), Lallemand Inc., Land O'Lakes, Inc., Leiber GmbH, Microbiome Insights, Inc., MicroSintesis, Native Microbials, NomNomNow Inc., Novozymes A/S, Novus International Inc., Ocean Harvest Technology, Orion Pharma Animal Health, Phage Technologies SA, Phagelux, Inc., Phibro Animal Health Corporation, Phytobiotics Futterzusatzstoffe GmbH, Primal Health, LLC, ProDigest, Proteon Pharmaceuticals, Pure Cultures, Purina Animal Nutrition, Resilient Biotics, Tonisity International Limited, Vetanco, VetoPhage, and List of Other prominent players.

Key Industry Developments from Leading Players:
• In Jan 2022, Felix Biotechnology announced a partnership with AnimalBiome to develop new solutions to address diarrhea in pets. Felix has several ongoing partnerships to develop phage-based solutions with personal care and cosmetic companies, and through this partnership, the company plans to expand its footprint into animal health.
• In Aug 2021, Chr. Hansen introduced a new product portfolio of stable live probiotics for use in pet foods and supplements, including Chr. Hansen Pet-Prostart, Chr. Hansen Pet-Proessentials and Chr. Hansen Pet-Provital. Followed to this, the company has introduced Bovacillus, a new solution to support dairy and beef cattle health and performance. Through these product launches, Chr. Hansen focuses on supporting healthy digestion, immunity, and overall wellbeing of animals.
• In Aug 2021, ISOThrive Inc. received a Composition of Matter and Production Method patent for its first Farmaceutical™ Maltosyl-Isomaltooligosaccharides (MIMO), a prebiotic for use as an animal feed additive and pet food supplement. Through this patent, the company has created emerging opportunities in pet health with supplements that support better digestion with less reliance on medications.
• In July 2021, Cargill invested in AnimalBiome to boost the introduction of new products and insights in the pet microbiome modulation space. Through this partnership with Cargill, AnimalBiome advances a clear leadership position in an exciting, growing market and creates novel products to restore balance to the gut microbiomes of companion animals.
• In Nov 2019, GNUbiotics Sciences announced a strategic agreement with Evonik Nutrition & Care to manufacture GNUbiotics' Animal Milk Oligosaccharide, AMObiome™. First-in-class Animal Milk Oligosaccharide AMObiome™ to respond to the increasing demand for natural break-through products for companion and production animal health

Animal Microbiome Market Regional Analysis:
Asia and Europe accounted for the largest revenue share in 2021 and are further anticipated to expand with the fastest CAGR from 2022-to 2030. Improved research and development activities, Technological advancements, and an increasing number of pet owners are the factors driving the animal microbiome market growth in the Region. The Asia Pacific is also projected to offer significant growth opportunities during the forecast period owing to rising animal health awareness, cumulative pet population, along the growing number of government initiatives to promote animal health.

Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1046

The Global Animal Microbiome Market Segments
The Global Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product
• Phage Therapy Product
• Functional Food
o Probiotics
o Prebiotics
o Others
• Sequencing Platforms
• Feed Additives/Functional Ingredients
• Alternative Proteins and Alternative Feed
• Other Innovative Microbiome Products and Therapies

The Global Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Application
• Disease Therapeutics
• Diagnostics
• Nutrition

The Global Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Animal Type
• Poultry
• Ruminants
• Swine
• Aquaculture
• Pets

The Global Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa

North America Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada

Europe Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of the Middle East & Africa

For Customised Information @ https://www.insightaceanalytic.com/report/global-animal-microbiome-market/1046

InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: https://www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Follow Us @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/

Subscribe Our Exclusive Newsletters @ https://www.linkedin.com/newsletters/latest-market-research-reports-6929319878155739136/

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.